Literature DB >> 24584822

Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer.

Timothy L Lash1, Soe Soe Thwin, Marianne Ulcickas Yood, Ann M Geiger, Jaclyn Bosco, Virginia P Quinn, Terry S Field, Pamala A Pawloski, Rebecca A Silliman.   

Abstract

Late effects of breast cancer affect the quality of survivorship. Using administrative data, we compared the occurrence of almost all ICD9 codes among older breast cancer survivors to that among a matched comparison cohort to generate new hypotheses. Breast cancer patients 65 years or older diagnosed 1990-1994 in 6 integrated care settings and who survived at least 5 years were matched with a cohort of women without a history of breast cancer on care setting, age, and calendar time. We collected data on the occurrence of incident ICD9 codes beginning 6 years after the breast cancer diagnosis date and continuing to year 15, and comparable data for the matched woman. We calculated hazard ratios (HRs) and 95 % confidence intervals associating breast cancer survivorship with incidence of each ICD9 code. We used semi-Bayes methods to address multiple comparisons. Older breast cancer survivors had about the same occurrence of diseases and conditions 6-15 years after breast cancer diagnosis as comparable women. The median of 564 adjusted HRs equaled 1.06, with interquartile range 0.92-1.3. The distribution of HRs pertaining to cancer-related ICD codes was shifted toward positive associations, and the distribution pertaining to cardiovascular-related ICD codes was shifted toward negative associations. In this hypothesis-scanning study, we observed little difference in the occurrence of non-breast cancer-related diseases and conditions among older, long-term breast cancer survivors, and comparable women without a history of breast cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24584822      PMCID: PMC4319216          DOI: 10.1007/s10549-014-2885-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  29 in total

1.  Empirical-Bayes adjustments for multiple comparisons are sometimes useful.

Authors:  S Greenland; J M Robins
Journal:  Epidemiology       Date:  1991-07       Impact factor: 4.822

2.  Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.

Authors:  Brian D Bradbury; Timothy L Lash; James A Kaye; Susan S Jick
Journal:  Cancer       Date:  2005-03-15       Impact factor: 6.860

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  The health of older-adult, long-term cancer survivors.

Authors:  Gary T Deimling; Samantha Sterns; Karen F Bowman; Boaz Kahana
Journal:  Cancer Nurs       Date:  2005 Nov-Dec       Impact factor: 2.592

Review 5.  Building a research consortium of large health systems: the Cancer Research Network.

Authors:  Edward H Wagner; Sarah M Greene; Gene Hart; Terry S Field; Suzanne Fletcher; Ann M Geiger; Lisa J Herrinton; Mark C Hornbrook; Christine C Johnson; Judy Mouchawar; Sharon J Rolnick; Victor J Stevens; Stephen H Taplin; Dennis Tolsma; Thomas M Vogt
Journal:  J Natl Cancer Inst Monogr       Date:  2005

6.  Breast cancer treatment of older women in integrated health care settings.

Authors:  Shelley M Enger; Soe Soe Thwin; Diana S M Buist; Terry Field; Floyd Frost; Ann M Geiger; Timothy L Lash; Marianne Prout; Marianne Ulcickas Yood; Feifei Wei; Rebecca A Silliman
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

7.  Empirical Bayes adjustments for multiple results in hypothesis-generating or surveillance studies.

Authors:  K Steenland; I Bray; S Greenland; P Boffetta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-09       Impact factor: 4.254

8.  Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis.

Authors:  Patricia A Ganz; Edward Guadagnoli; Mary Beth Landrum; Timothy L Lash; William Rakowski; Rebecca A Silliman
Journal:  J Clin Oncol       Date:  2003-11-01       Impact factor: 44.544

9.  Fracture risk in older, long-term survivors of early-stage breast cancer.

Authors:  Pamala A Pawloski; Ann M Geiger; Reina Haque; Aruna Kamineni; Hassan Fouayzi; Jessica Ogarek; Hans V Petersen; Jaclyn L F Bosco; Soe Soe Thwin; Rebecca A Silliman; Terry S Field
Journal:  J Am Geriatr Soc       Date:  2013-05-06       Impact factor: 7.538

View more
  3 in total

1.  Metastatic Breast Cancer Collateral Damage Project (MBCCD): Scale development and preliminary results of the Survey of Health, Impact, Needs, and Experiences (SHINE).

Authors:  Timothy J Williamson; Susan M Love; Jessica N Clague DeHart; Alexandra Jorge-Miller; Leah Eshraghi; Heather Cooper Ortner; Annette L Stanton
Journal:  Breast Cancer Res Treat       Date:  2018-05-16       Impact factor: 4.872

2.  Improving communication within the interdisciplinary team monitoring young women with onco-gynecological pathology in Romania.

Authors:  Ioan Lancrajan; Ioan Lisencu; Laurentiu Ignat; Rares Trisca; Madalina Coman; Floarea Mocean
Journal:  Clujul Med       Date:  2018-07-31

3.  Disease trajectories and mortality among women diagnosed with breast cancer.

Authors:  Haomin Yang; Yudi Pawitan; Wei He; Louise Eriksson; Natalie Holowko; Per Hall; Kamila Czene
Journal:  Breast Cancer Res       Date:  2019-08-16       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.